MedTrace Logo

3D Modalities for Medical Student Education of Congenital Heart Disease

NCT07295730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-12-26

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are:

1. Does using 3D-printed heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods?
2. Does using augmented reality heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods?
3. How can these modalities best be integrated into standard medical school curricula?

Participants will:

1. Take a pre-test consisting of questions regarding anatomy and physiology of the normal heart as well as two congenital heart diseases.
2. Be randomized into 3 groups that receive a teaching session using either slide-based lecture, 3D-printed models, or augmented reality.
3. Take a post-test of the same questions from the pre-test.
4. Take a delayed post-test of the same questions with additional subjective questions about their experience with their assigned modality.

Conditions

  • Tetralogy of Fallot (TOF)
  • Hypoplastic Left Heart Syndrome (HLHS)

Interventions

OTHER

3D-printed heart models and augmented reality

Participants will receive an educational session regarding congenital heart disease using a slide-based lecture, 3D-printed models, or augmented reality headsets.

Sponsors & Collaborators

  • Case Western Reserve University

    lead OTHER

Principal Investigators

  • Arpit Agarwal, MD · University Hospitals Cleveland Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-20
Primary Completion
2025-12-09
Completion
2025-12-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07295730 on ClinicalTrials.gov